Skip to main content

Table 1 VITAH trial inclusion and exclusion criteria

From: The VITAH Trial Vitamin D supplementation and cardiac autonomic tone in hemodialysis: a blinded, randomized controlled trial

Inclusion criteria

Exclusion criteria

• Age ≥ 18 years

• Any major cardiovascular event within the last 6 months prior to enrolment (this includes, but is not limited to, new onset arrhythmia, hospitalization for a cardiovascular complication)

• Thrice weekly hemodialysis outpatient within the Southern Alberta Renal Program

 

• Physician consent to participate

• Refusal to cease vitamin D therapy for four (4) weeks prior to initiation of the study

• Ability and agreement to cease any prior vitamin D medication for four (4) weeks prior to initiation of the study

• Palliative status or metastatic malignancy

• Ability to comprehend study protocol and provide oral and written consent in English (native language or translated)

• Known or anticipated upcoming change in dialysis modality including transfer to peritoneal dialysis, kidney transplant, or change in current hemodialysis schedule/duration